Evidence map›Paper›PMID 42186973›Full record

ArticleBiochemistry2026

Structural Basis for Potassium Inhibition of WNK Kinases.

Elizabeth J Goldsmith, John M Pleinis, Armin Wagner, Vitaliy Mykhaylyk, Radha Akella, John M Humphreys, Haixia He, Logan Norrell, Daryl E Morrison, Aylin R Rodan

Abstract read
In one paragraph

Article in Biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizabeth J GoldsmithDepartment of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States.ORCID 0000-0001-8102-5012
John M PleinisMolecular Medicine Program, University of Utah, Salt Lake City, Utah 84112, United States.
Armin WagnerDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, U.K.
Vitaliy MykhaylykDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, U.K.ORCID 0000-0003-0106-2724
Radha AkellaDepartment of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States.
John M HumphreysDepartment of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States.
Haixia HeDepartment of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States.
Logan NorrellMolecular Medicine Program, University of Utah, Salt Lake City, Utah 84112, United States.
Daryl E MorrisonMolecular Medicine Program, University of Utah, Salt Lake City, Utah 84112, United States.
Aylin R RodanMolecular Medicine Program, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0001-9202-2378

Funding

Regulation of WNK signaling by potassium and Mo25: structure, function and physiologyR01DK110358 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RODAN, AYLIN RACHEL · 2016 to 2025
$4.1M
NIDDK NIH HHS R01 DK110358
6 · The paper itself

Abstract

WNK kinases are chloride- and osmotic-stress-regulated protein kinases recently shown to be controlled by potassium. Prior studies demonstrated the direct binding of chloride and osmotic stress-related water in WNK kinase regulation. Here, we probe potassium binding and regulation of WNK kinases via crystallography coupled with mutagenic analysis of WNK kinase autophosphorylation and activity. Crystals of unphosphorylated WNK1 grown in cesium formate, a surrogate for potassium, yielded nonsulfur scattering peaks at 5.75 keV. Mutations were introduced into amino acids flanking the anomalous diffraction peaks. Mutations in WNK1/E388 and the corresponding WNK3/E314, probing a peak close to WNK1/I384, led to reduced inhibition by potassium while maintaining kinase autophosphorylation and substrate phosphorylation activity. Other peaks probed by mutagenesis either did not bear out as potassium regulatory sites or were not validated due to the inactivity of the mutants synthesized. Previously synthesized chloride- and water-binding mutants demonstrate correlated sensitivity to chloride and potassium. Potassium, chloride, and water are all WNK inhibitors that share a common mechanism binding the same low-activity asymmetric dimer of WNK1 kinase domains.

Indexed as

PotassiumProtein Kinase InhibitorsProtein Serine-Threonine KinasesWNK Lysine-Deficient Protein Kinase 1Binding SitesChloridesCrystallography, X-RayHumansModels, MolecularMutationPhosphorylationWaterChloridesPotassiumProtein Kinase InhibitorsProtein Serine-Threonine KinasesWaterWNK1 protein, humanWNK3 protein, humanWNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID42186973
PMCPMC13397483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.